Cellia Science Awarded National Institutes of Health Phase I SBIR Funding
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and
February 13, 2023
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and
Fayetteville, AR – Cellia Science, a point-of-care hematology company, announced today that it has been awarded a Small Business Innovation
2022 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive
Bringing a proven track record in healthcare operations, innovation, and investing. FAYETTEVILLE, AR- VIC Technology Venture Development is pleased to
As CEO of VIC Tech, I am fortunate to have the opportunity to review exciting new life science technologies on
Remote photoplethysmography (rPPG) has the potential to greatly expand telemedicine capabilities. In this article, I provide information about what this
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and
Dramatic life science advancements are emerging that are likely to transform healthcare over the next 20 years. For example, continued
As Cellia Science approaches the first anniversary of our formation, I am pleased to reflect on the progress we have
In Part 1 of this series, I touched on some of the unique considerations for advancing early-stage innovation beyond the
The University of California San Francisco (UCSF) Health Awards named CardioWise, Inc. as a Rising Star in the Clinical Diagnostic
Please describe your background/career path that led you to your current role. I received my Doctorate in Toxicology and Molecular